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Background
GullianBarre Syndrome is the most common cause of 
acute flaccid quariparesis.One of the important 
differential of GBS is hypokalemia which is not only 
clinically similar but also gives similar changes in nerve 
conduction studies.We are presenting two cases of 
hyperkalemia which were initially admitted with 
suspicion of GBS but laboratory tests showed 
hyperkalemia.When we did nerve conductionstudies,
changes were very similar to GBS.Moreover, 
electrophysiological changes improved with treatment 
of hyperkalemia.
Case 1
70 years old patient presented in the neurology 
outpatient clinic withprogressive weakness of all four 
limbs for the last 1 week.It was preceded by a diarrheal 
illness that settled spontaneously. Weakness started in 
the legs, and for last 2 days it involved the arms as 
well.She was having mild numbness of arms as well. 
She had normal sphincter control and did not have any 
difficulty in breathing or swallowing. The rest of her 
neurological inquiries likeconsciousness,vision,hearing,
speech,comprehension were normal.Systemic inquiries 
were normal. She was havingdiabetes mellitus and 
hypertension.On examination, she was well oriented 
with normal vital signs. Her cranial nerves examination 
was normal. Power was MRC Grade 4/5 in all four 
limbs.Her reflexes were diminished and planters were 
flexor bilaterally. There was stockings type sensory loss 
in the legs.
Table 1. Baseline investigation (Case1)
She was admitted in the High Dependency area, she 
developed bradycardia,breathing difficulty and was 
intubated and put on ventilator.Immediate nephrology 
consult was sought and hemodialysis started.  Nerve 
conduction studieswere done (Fig 2a) which showed 
acute demyelinating neuropathy probably 
superimposed on background diabetic axonal 
neuropathy. Repeat NCS done 72 hours later showed 
marked improvement (Fig 2b).
Next day the patient improved , she was extubated. 
Serum potassium and sodium repeated after dialysis 
was 4.4 and 131 respectively.She was clinically 
improving and started to walk with support.
Case 2
Forty three years old male, known diabetic for the last 
20 years. He suffered from end stage renal disease and 
was on regular hemodialysis when he missed his 
scheduled dialysis. He presented in emergency 
department with difficulty in getting up from chair.He 
was well before that and was able to walk but for last 3 
days he developed weakness of limbs and was unable 
to get up from chair. He also had a history of 
gastroenteritis 2 days before onset of weakness.He was 
had a family history of diabetes mellitus,hypertension 
and chronic kidney disease.Drug history includes using 
insulin, tab Carvedilol 6.25 mg 1+1,tabHydralazine 
1+1,tab Aspirin 75 QD,Calcium and vitamin D 
supplements.His general physical and systemic 
examination was normal. Power on MRC scale was 5/5 
in upper limbs, it was 3/5 in lower limbs, with absent 
reflexes and flexor plantars. Cranial nerve,sensory 
system and cerebellar examination were normal. The 
patient was admitted in High Depenency unit and 
dialysis started. Patient started to improve as his serum 
potassium was corrected.
Discussion
GullianBarre syndrome is a post-infectious 
polyneuropathy which presents as 
acuteflaccidquariparesis.Low serum potassium level 
can present with weakness mimicking GBS1. 
Hypokalemia is relatively a common disorder causing 
acute flaccid weakness of limbs. In patients presenting 
with acute flaccid quadriparesis, we should check 
serum potassium before making 
diagnosingGullianBarre Syndrome.Hyperkalemia can 
also causeweakness of limbsand is rare cause of 
weakness mimicking GBS.It is an ascending type of 
weakness that ascends upward from legs to arms and 
trunk.Cranial nerves ,sensations and sphincters remain 
intact and respiratory failure is rare2.
Primary hyperkalemic paralysis which is a genetic 
disease of sodium channel is common and usually 
presents in the first decade of life but secondary 
hyperkalemia leading to acute flaccid quadriparesis is 
anuncommon phenomenon3,4.Here we have 
presented two cases ofacute flaccid weaknesswho 
were initially  admitted with a suspicion of GBS but later 
on they were found to have hyperkalemia.
Electrophysiological studies of bothcases showed 
prolonged distal latencies and decreased conduction 
velocities on presentation .In both patients,immediate 
dialysis was done to correct serum potassium and they 
improved.In first patient we repeated studies after 72 
hours and they were significantly improved and some 
axonal neuropathic features were present because of 
underlying diabetic axonal polyneuropathy.In second 
patient studies repeated after 24 hours and they 
showed mild improvement in all parameters. The 
proposed mechanism of hyperkalemia induced 
paralysis is either effect of high potassium on muscle 
fibers and cell membranes orit might be associated 
with neuropathy by high serum potassium level5,6.High 
potassium also inactivates sodium channel and it 
would cause impairment of action potential generation 
and lead to reduced amplitudes of sensorimotor 
nerves7.Impairment of nerve conduction leads to 
prolonged latencies ,conduction blocks and decreased 
conduction velocities8.These changes are reversible as 
evident in our cases and they should be done after 
three days of correction of poatssium as seen in our 
first case where most of nerve conduction changes 
have improvedsignificantly. The changes seen in both 
cases are predominantly demylinating with prolonged 
latencies and decreased conduction velocities and 
some reduction in amplitudes of combined muscle 
action potentials.Hyperkalemia induced weakness is 
very similar to GBS and electrophysiological studies 
may show changes similar to it.Sensory system usually 
remains normal in both hyperkalemic paralysis and 
GBS9,autonomic dysfunction is a feature of GBS and 
not associated with hyperkalemia, however arrhythmias 
may occur due to hyperkalemia10. We suggest that 
Serum potassium must be checked before diagnosing 
GBS as treatment is completely different.
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ABSTRACT
OBJECTIVE;To know about surgical outcome of benign intracranial hypertension in terms of improvement of 
vision.METHODOLOGY ; This Prospective observational  study  was conducted at of 22 patients operated in 
neurosurgery unit lady reading hospital Peshawar from Jan 2011 to Jun2014. Written consent was obtained from all 
the patients or their relatives All patients of either age and  sex with Diagnosed cases of  BIH were included in the study, 
Patients with depressed conscious level, malignant hypertension, space occupying lesion in brain on MRI and those 
Patients unfit or  unwilling for surgery were excluded from the study.  Patients particulars like age ,gender , and post 
operative outcome was documented on predesigned proforma . All the results were analyzed by spss version 16 and 
represented in the form o graphs/charts and tables. RESULTS;- Total 22 patients of BIH were studied which were all 
females (100%) having age range of 18 to 58 years  with mean of  38 ± 5 years SD. Headache was present in all 
(100%) patients followed by visual  deterioration having  20(90.90%) cases. CSF manometery showed opening 
pressure from 28cm of H2O to 50 cm of H2O, with mean of 39. 19.  Post operatively headache improved in 16(72%) 
patients, Papilledema in 18(81.81%) caseswhile 4(18%) patients did not improved.  In 2(9.09%) cases there was and 
CSF leak was in 1(4.54%) case.CONCLUSION; BIH has good surgical outcome in terms of improvement in vision, if 
managed before advanced stage of Papilledema 
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INTRODUCTION
Benign intracranial hypertension (BIH) or 
pseudotumourcerebri is defined as a syndrome of signs 
and symptoms of increased intracranial pressure 
without clinical, laboratory or radiologic evidence of 
causative lesions on magnetic resonance imaging 
(MRI) or computed tomography1.  BIH occurs most 
commonly in obese women of reproductive age. The 
incidence is approximately 1/100 000/year rising to 
13/100 000/ year in women who are 10% above ideal 
body weight  between 20 and 44 years. BIH less 
frequently seen in males and children.Prevalence rates 
are higher, showing the chronic nature of the condition 
in majority cases2,3,4,5. Average age at the time of 
diagnosis Benign intracranial Hypertension  is 30 
years6. Some medications  such as steroid withdrawal, 
lithium, tetracycline’s, and vitamin analogs and 
systemic conditions  such as  obstructive sleep apnea, 
renal failure, coagulopathies, and anemia have also 
been associated with BIH6,7,8. Cerebral venous 
hypertension due to  Dural venous sinus thrombosis, 
neoplastic obstruction of siuses or a duralarteriovenous 
malformation causes a very similar clinical picture and 
diagnosis of BIH is made when cerebral venous 
obstruction and other causes of raised intracranial 
pressure have been ruled out on Neuroimaging9.The 
symptoms of BIH patients are headache (94%), 
transient visual obscurations (68%), pulse-synchronous 
tinnitus (58%), photopsia (54%), and retrobulbar pain 
(44%). Diplopia (38%) and visual loss (30%) are less 
commonly  features of BIH10. To diagnose BIH we 
should have (1) Raised intracranial pressure; (2) 
Normal neurologic examination except  Papilledema 
and an occasionally abducens nerve palsy (3) the 
absence of a space-occupying lesion, or ventricular 
enlargement on computed tomography or magnetic 
resonance imaging; and (4) a normal cerebrospinal 
fluid composition10,11,12.In addition to these 
features CSF manometery is of diagnostic and 
therapeutic importance. CSF  opening pressure greater 
than 250 mm H2O is diagnostic, less than 200 mm 
H2O is normal, and 201 to 249 mm H2O is 
nondiagnostic13.Management  aim is controlling 
symptoms of raised intracranial pressure (ICP) and 
prevention of loss of vision due to Papilledema.Dietary 
modification and weight loss are time part of initial 
managment14,15 , Repeated  lumber puncture are 
sometimes used in patients to control symptom , in 
pregnant women, or in the setting of rapidly declining 
vision to temporarily lower16 and optimize  the CSF 
pressure. Acetazolamide  a carbonic anhydrase 
inhibitor is used  for lowering the intracranial 
hypertension by decreasing CSF production (Doses of 1 
to 2 g ).Surgical treatment is indicated in cases with 
failed medical treatment or rapidly deteriorating vision. 
Generally, the indication for a CSF diversion procedure 
is failed medical treatment or intractable headache17. 
There are many surgical treatment options like 
lumboperitoneal shunt18,19,20 optic nerve sheath 
fenestration21,22, ventriculoperitoneal (VP) 
shunt23,24,25and venous sinus stenting for patients 
of BIH26,27 . Currently Lumboperitoneal shunt is most 
commonly advised to patients of BIH. As vision 
deterioration and headache are the  most common 
presenting and disabling feature of patients with BIH, 
therefore we conducted this study to determine 
outcome of lumboperitoneal shunt in patients with BIH 
in terms of improvement in vision..
Material and methods
We conducted  this Prospective observational  study of 
22 patients operated in neurosurgery unit lady reading 
hospital Peshawar   from Jan 2011 to Jun2014. 
Written consent was obtained from all the patients or 
their relatives All patients of either age and  sex with 
Diagnosed cases of  BIH were included in the study, 
Patients with depressed conscious level, Malignant 
hypertension, Patients with space occupying lesion in 
brain on MRI, Patients unfit for surgery and unwilling for 
surgery were excluded from the study.Pre operative 
funds examination and visual field charting was done in 
all the cases. Pre-operatively CT scan /MRI brain was 
done in all the patients. MR venography was also done 
in all patients.  Cerebrospinal fluid examination was 
performed in all patients. All patients were admitted 
through OPD in ward. Preoperative work up was done in 
all cases. Hematologic tests like FBC,Urea,RBS, and 
Serologic tests like HBS and HCV were done for all 
cases. Lumboperitoneal shunt was done in all cases 
under G.A.
TECHNIQUE OF SURGERY
Position;Lateral decubitus position with both knee 
flexed.
Skin incision: 
1.5 to 2 cm at L3-L4 or L4-L5 level extended down to 
the lumber fascia overlying the spinous processes.  Tilt 
table to 30 degree Reverse Trendelenburg to Increase 
lumbar subarachnoid space. Then Insertion of 
14-gauge Tuohy needle in interspinous space to reach 
into the subarachnoid space, with opening directed 
rostrally. Removal of the trocar with insertion of shunt 
tube ( 8 to 10 cm).stabilization of catheter at back 
wound under lumber fascia with reservoir . 
Abdominal placement: 
Incision is made into anterior abdominal wall, extended 
down and peritoneum is opened. Then subcutaneous 
shunt passer is passed and redirected to back incision. 
shunt catheter stabilized with reservoir at back incision 
is passed through passer, and inserted into peritoneal 
cavity. the wound is then closed.After surgery all 
patients were kept in ward for 4 to 5 days and then 
discharged to home. All patients were followed up till 1 
year, with 2 months interval.Postoperatively clinical 
outcome was measured by History and Fundus 
examination and CT brain. Postoperative follow up was 
clinical with history and Fundoscopy, and radiological 
with CT brain.All data was collected and put in 
Performa. All data was analyzed using SPSS version 
20. Results were expressed in the form of 
tables/graphs/charts.
Results
We studied 22 patients with Diagnosed cases of BIH. 
All patients were female. Age ranged from 18 to 58 
with mean of 38 ± 5 years SD.  In pre operative signs 
and symptoms the commonest was headache which 
was present in all (100%) patients , Visual 
deterioration in 20(90.90%) patient and all (100 %) 
these patients had Papilledema. 6(27.7%) patients 
had vomiting , 6th nerve palsy in  2(9.09%) patients 
(Table no 1) . All patients were investigated to follow 
modified dandy criteria.  CT brain was done in 
10(45.45%) patients. MRI brain with MRV was done in 
all( 100%) patients. CSF manometery showed opening 
pressure from 28cm of H2O to 50 cm of H2O, with 
mean of 39.19. CSF composition was normal in all 
patients. MRI brain showed slit ventricles in 3(13.63%) 
cases. LP shunt was done for all 22(100%) cases. 
Postoperatively clinical outcome was measured by 
History and Fundus examination and CT brain uptill 1 
years by intervals of 2 months follow up. Headache 
improved in 16(72%) patients, Papilledema resolved 
postoperatively in 18(81.81%) cases and same 
number of patients 18(81.81%) showed improvement 
in vision.  4(18%) patients had persistence of 
symptoms postoperatively. Shunt infection was noticed 
in 2(9.09%) cases in first 4 weeks which was 
subsequently managed.  CSF leak was noticed in 
1(4.54%) case for which shunt revision was done 
(Graph no 1).
Table no 1; Pre operative signs and symptoms N=22
 
Graph no 1; Post operative outcome of BIH N=22
Discussion
Benign intracranial hypertension is characterized by 
Raised CSF pressure of unknown Reason. Resistance 
to  CSF outflow  appears to increase, so intracranial 
pressure also increases. Whether the increased 
resisance is due to outflow which is  obstructed at the 
level of the arachnoid granulations or outer lymphatic’s 
flow is unclear ,however BIH can result in blindness if 
inadequately treated but  effective options strategies 
are available 28.The initial criteria suggested by Walter 
Dandy have been modified now called modified dandy 
criteria. Patients who follow these criteria are 
diagnosed as having the BIH. Laboratory evaluation is 
normal but there is raised intracranial pressure29.In 
the review of our 3 years experience with 22 patients 
with IIH who underwent Lumboperitoneal shunts , we 
aimed to determine improvement in visual problems 
after surgery. In our study we had age ranged from 18 
to 58 years with mean of 38.and this correlates with 
Whitely and coworkers who prospectively had  peak 
incidence of disease  in 3rd decade of life30.
The disease is more common in women of child bearing 
age. we had all patients female 22(100%) had BIH in 
three years duration. and explanation is consistent with 
the hormonal theory for pathogenesis of  BIH which 
states that high incidence among obese women  as 
adipocytes covert androstenedione to estrone which 
increases CSF production31. Study conducted by 
Yadav YRetal32 also showed this disease in 90.90% 
patients, which closely correlates to our study. 
Headache and vision deterioration are common 
problems in patients with BIH. We had headache in all 
(100%) patients and vision deterioration in 
20(90.90%) patients. It is comparable with study of 
Corbett and colleagues33, who also had  the same 
incidence (100 % of cases) in their series which 
included 20 patients with BIH.  There are many surgical 
treatment options for BIH management which includes 
Lumboperitoneal shunting, Ventriculoperitoneal 
shunting, and optic nerve sheath decompression. 
Cerebrospinal fluid shunting is the most widely 
performed surgical treatment for BIH and it is useful in 
the treatment of Papilledema, headache, and visual 
loss. We did Lumboperitoneal shunting for all(100%) 
patients. Postoperatively headache and Visual 
symptoms improved in 16(72%), and 18(81.81%) 
consecutively. In another international study by Burgett, 
etal34.described an 82% success rate of postoperative 
headache relief and visual improvement in patients 
with LP shunts. So our results are comparable with their 
results. Purvin VA et al35, had studied 30 patients who 
underwent LP shunting for treatment of BIH. Out of 14 
patients with impaired acuity, 10 eyes (71%) improved 
after shunting, which is less as compared to our 81%. 
on subsequent follow up visits 3(13.63%) patients had 
low pressure headache which was conservatively 
managed.
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C A S E  R E P O R T
Background
GullianBarre Syndrome is the most common cause of 
acute flaccid quariparesis.One of the important 
differential of GBS is hypokalemia which is not only 
clinically similar but also gives similar changes in nerve 
conduction studies.We are presenting two cases of 
hyperkalemia which were initially admitted with 
suspicion of GBS but laboratory tests showed 
hyperkalemia.When we did nerve conductionstudies,
changes were very similar to GBS.Moreover, 
electrophysiological changes improved with treatment 
of hyperkalemia.
Case 1
70 years old patient presented in the neurology 
outpatient clinic withprogressive weakness of all four 
limbs for the last 1 week.It was preceded by a diarrheal 
illness that settled spontaneously. Weakness started in 
the legs, and for last 2 days it involved the arms as 
well.She was having mild numbness of arms as well. 
She had normal sphincter control and did not have any 
difficulty in breathing or swallowing. The rest of her 
neurological inquiries likeconsciousness,vision,hearing,
speech,comprehension were normal.Systemic inquiries 
were normal. She was havingdiabetes mellitus and 
hypertension.On examination, she was well oriented 
with normal vital signs. Her cranial nerves examination 
was normal. Power was MRC Grade 4/5 in all four 
limbs.Her reflexes were diminished and planters were 
flexor bilaterally. There was stockings type sensory loss 
in the legs.
Table 1. Baseline investigation (Case1)
She was admitted in the High Dependency area, she 
developed bradycardia,breathing difficulty and was 
intubated and put on ventilator.Immediate nephrology 
consult was sought and hemodialysis started.  Nerve 
conduction studieswere done (Fig 2a) which showed 
acute demyelinating neuropathy probably 
superimposed on background diabetic axonal 
neuropathy. Repeat NCS done 72 hours later showed 
marked improvement (Fig 2b).
Next day the patient improved , she was extubated. 
Serum potassium and sodium repeated after dialysis 
was 4.4 and 131 respectively.She was clinically 
improving and started to walk with support.
Case 2
Forty three years old male, known diabetic for the last 
20 years. He suffered from end stage renal disease and 
was on regular hemodialysis when he missed his 
scheduled dialysis. He presented in emergency 
department with difficulty in getting up from chair.He 
was well before that and was able to walk but for last 3 
days he developed weakness of limbs and was unable 
to get up from chair. He also had a history of 
gastroenteritis 2 days before onset of weakness.He was 
had a family history of diabetes mellitus,hypertension 
and chronic kidney disease.Drug history includes using 
insulin, tab Carvedilol 6.25 mg 1+1,tabHydralazine 
1+1,tab Aspirin 75 QD,Calcium and vitamin D 
supplements.His general physical and systemic 
examination was normal. Power on MRC scale was 5/5 
in upper limbs, it was 3/5 in lower limbs, with absent 
reflexes and flexor plantars. Cranial nerve,sensory 
system and cerebellar examination were normal. The 
patient was admitted in High Depenency unit and 
dialysis started. Patient started to improve as his serum 
potassium was corrected.
Discussion
GullianBarre syndrome is a post-infectious 
polyneuropathy which presents as 
acuteflaccidquariparesis.Low serum potassium level 
can present with weakness mimicking GBS1. 
Hypokalemia is relatively a common disorder causing 
acute flaccid weakness of limbs. In patients presenting 
with acute flaccid quadriparesis, we should check 
serum potassium before making 
diagnosingGullianBarre Syndrome.Hyperkalemia can 
also causeweakness of limbsand is rare cause of 
weakness mimicking GBS.It is an ascending type of 
weakness that ascends upward from legs to arms and 
trunk.Cranial nerves ,sensations and sphincters remain 
intact and respiratory failure is rare2.
Primary hyperkalemic paralysis which is a genetic 
disease of sodium channel is common and usually 
presents in the first decade of life but secondary 
hyperkalemia leading to acute flaccid quadriparesis is 
anuncommon phenomenon3,4.Here we have 
presented two cases ofacute flaccid weaknesswho 
were initially  admitted with a suspicion of GBS but later 
on they were found to have hyperkalemia.
Electrophysiological studies of bothcases showed 
prolonged distal latencies and decreased conduction 
velocities on presentation .In both patients,immediate 
dialysis was done to correct serum potassium and they 
improved.In first patient we repeated studies after 72 
hours and they were significantly improved and some 
axonal neuropathic features were present because of 
underlying diabetic axonal polyneuropathy.In second 
patient studies repeated after 24 hours and they 
showed mild improvement in all parameters. The 
proposed mechanism of hyperkalemia induced 
paralysis is either effect of high potassium on muscle 
fibers and cell membranes orit might be associated 
with neuropathy by high serum potassium level5,6.High 
potassium also inactivates sodium channel and it 
would cause impairment of action potential generation 
and lead to reduced amplitudes of sensorimotor 
nerves7.Impairment of nerve conduction leads to 
prolonged latencies ,conduction blocks and decreased 
conduction velocities8.These changes are reversible as 
evident in our cases and they should be done after 
three days of correction of poatssium as seen in our 
first case where most of nerve conduction changes 
have improvedsignificantly. The changes seen in both 
cases are predominantly demylinating with prolonged 
latencies and decreased conduction velocities and 
some reduction in amplitudes of combined muscle 
action potentials.Hyperkalemia induced weakness is 
very similar to GBS and electrophysiological studies 
may show changes similar to it.Sensory system usually 
remains normal in both hyperkalemic paralysis and 
GBS9,autonomic dysfunction is a feature of GBS and 
not associated with hyperkalemia, however arrhythmias 
may occur due to hyperkalemia10. We suggest that 
Serum potassium must be checked before diagnosing 
GBS as treatment is completely different.
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INTRODUCTION
Benign intracranial hypertension (BIH) or 
pseudotumourcerebri is defined as a syndrome of signs 
and symptoms of increased intracranial pressure 
without clinical, laboratory or radiologic evidence of 
causative lesions on magnetic resonance imaging 
(MRI) or computed tomography1.  BIH occurs most 
commonly in obese women of reproductive age. The 
incidence is approximately 1/100 000/year rising to 
13/100 000/ year in women who are 10% above ideal 
body weight  between 20 and 44 years. BIH less 
frequently seen in males and children.Prevalence rates 
are higher, showing the chronic nature of the condition 
in majority cases2,3,4,5. Average age at the time of 
diagnosis Benign intracranial Hypertension  is 30 
years6. Some medications  such as steroid withdrawal, 
lithium, tetracycline’s, and vitamin analogs and 
systemic conditions  such as  obstructive sleep apnea, 
renal failure, coagulopathies, and anemia have also 
been associated with BIH6,7,8. Cerebral venous 
hypertension due to  Dural venous sinus thrombosis, 
neoplastic obstruction of siuses or a duralarteriovenous 
malformation causes a very similar clinical picture and 
diagnosis of BIH is made when cerebral venous 
obstruction and other causes of raised intracranial 
pressure have been ruled out on Neuroimaging9.The 
symptoms of BIH patients are headache (94%), 
transient visual obscurations (68%), pulse-synchronous 
tinnitus (58%), photopsia (54%), and retrobulbar pain 
(44%). Diplopia (38%) and visual loss (30%) are less 
commonly  features of BIH10. To diagnose BIH we 
should have (1) Raised intracranial pressure; (2) 
Normal neurologic examination except  Papilledema 
and an occasionally abducens nerve palsy (3) the 
absence of a space-occupying lesion, or ventricular 
enlargement on computed tomography or magnetic 
resonance imaging; and (4) a normal cerebrospinal 
fluid composition10,11,12.In addition to these 
features CSF manometery is of diagnostic and 
therapeutic importance. CSF  opening pressure greater 
than 250 mm H2O is diagnostic, less than 200 mm 
H2O is normal, and 201 to 249 mm H2O is 
nondiagnostic13.Management  aim is controlling 
symptoms of raised intracranial pressure (ICP) and 
prevention of loss of vision due to Papilledema.Dietary 
modification and weight loss are time part of initial 
managment14,15 , Repeated  lumber puncture are 
sometimes used in patients to control symptom , in 
pregnant women, or in the setting of rapidly declining 
vision to temporarily lower16 and optimize  the CSF 
pressure. Acetazolamide  a carbonic anhydrase 
inhibitor is used  for lowering the intracranial 
hypertension by decreasing CSF production (Doses of 1 
to 2 g ).Surgical treatment is indicated in cases with 
failed medical treatment or rapidly deteriorating vision. 
Generally, the indication for a CSF diversion procedure 
is failed medical treatment or intractable headache17. 
There are many surgical treatment options like 
lumboperitoneal shunt18,19,20 optic nerve sheath 
fenestration21,22, ventriculoperitoneal (VP) 
shunt23,24,25and venous sinus stenting for patients 
of BIH26,27 . Currently Lumboperitoneal shunt is most 
commonly advised to patients of BIH. As vision 
deterioration and headache are the  most common 
presenting and disabling feature of patients with BIH, 
therefore we conducted this study to determine 
outcome of lumboperitoneal shunt in patients with BIH 
in terms of improvement in vision..
Material and methods
We conducted  this Prospective observational  study of 
22 patients operated in neurosurgery unit lady reading 
hospital Peshawar   from Jan 2011 to Jun2014. 
Written consent was obtained from all the patients or 
their relatives All patients of either age and  sex with 
Diagnosed cases of  BIH were included in the study, 
Patients with depressed conscious level, Malignant 
hypertension, Patients with space occupying lesion in 
brain on MRI, Patients unfit for surgery and unwilling for 
surgery were excluded from the study.Pre operative 
funds examination and visual field charting was done in 
all the cases. Pre-operatively CT scan /MRI brain was 
done in all the patients. MR venography was also done 
in all patients.  Cerebrospinal fluid examination was 
performed in all patients. All patients were admitted 
through OPD in ward. Preoperative work up was done in 
all cases. Hematologic tests like FBC,Urea,RBS, and 
Serologic tests like HBS and HCV were done for all 
cases. Lumboperitoneal shunt was done in all cases 
under G.A.
TECHNIQUE OF SURGERY
Position;Lateral decubitus position with both knee 
flexed.
Skin incision: 
1.5 to 2 cm at L3-L4 or L4-L5 level extended down to 
the lumber fascia overlying the spinous processes.  Tilt 
table to 30 degree Reverse Trendelenburg to Increase 
lumbar subarachnoid space. Then Insertion of 
14-gauge Tuohy needle in interspinous space to reach 
into the subarachnoid space, with opening directed 
rostrally. Removal of the trocar with insertion of shunt 
tube ( 8 to 10 cm).stabilization of catheter at back 
wound under lumber fascia with reservoir . 
Abdominal placement: 
Incision is made into anterior abdominal wall, extended 
down and peritoneum is opened. Then subcutaneous 
shunt passer is passed and redirected to back incision. 
shunt catheter stabilized with reservoir at back incision 
is passed through passer, and inserted into peritoneal 
cavity. the wound is then closed.After surgery all 
patients were kept in ward for 4 to 5 days and then 
discharged to home. All patients were followed up till 1 
year, with 2 months interval.Postoperatively clinical 
outcome was measured by History and Fundus 
examination and CT brain. Postoperative follow up was 
clinical with history and Fundoscopy, and radiological 
with CT brain.All data was collected and put in 
Performa. All data was analyzed using SPSS version 
20. Results were expressed in the form of 
tables/graphs/charts.
Results
We studied 22 patients with Diagnosed cases of BIH. 
All patients were female. Age ranged from 18 to 58 
with mean of 38 ± 5 years SD.  In pre operative signs 
and symptoms the commonest was headache which 
was present in all (100%) patients , Visual 
deterioration in 20(90.90%) patient and all (100 %) 
these patients had Papilledema. 6(27.7%) patients 
had vomiting , 6th nerve palsy in  2(9.09%) patients 
(Table no 1) . All patients were investigated to follow 
modified dandy criteria.  CT brain was done in 
10(45.45%) patients. MRI brain with MRV was done in 
all( 100%) patients. CSF manometery showed opening 
pressure from 28cm of H2O to 50 cm of H2O, with 
mean of 39.19. CSF composition was normal in all 
patients. MRI brain showed slit ventricles in 3(13.63%) 
cases. LP shunt was done for all 22(100%) cases. 
Postoperatively clinical outcome was measured by 
History and Fundus examination and CT brain uptill 1 
years by intervals of 2 months follow up. Headache 
improved in 16(72%) patients, Papilledema resolved 
postoperatively in 18(81.81%) cases and same 
number of patients 18(81.81%) showed improvement 
in vision.  4(18%) patients had persistence of 
symptoms postoperatively. Shunt infection was noticed 
in 2(9.09%) cases in first 4 weeks which was 
subsequently managed.  CSF leak was noticed in 
1(4.54%) case for which shunt revision was done 
(Graph no 1).
Table no 1; Pre operative signs and symptoms N=22
 
Graph no 1; Post operative outcome of BIH N=22
Discussion
Benign intracranial hypertension is characterized by 
Raised CSF pressure of unknown Reason. Resistance 
to  CSF outflow  appears to increase, so intracranial 
pressure also increases. Whether the increased 
resisance is due to outflow which is  obstructed at the 
level of the arachnoid granulations or outer lymphatic’s 
flow is unclear ,however BIH can result in blindness if 
inadequately treated but  effective options strategies 
are available 28.The initial criteria suggested by Walter 
Dandy have been modified now called modified dandy 
criteria. Patients who follow these criteria are 
diagnosed as having the BIH. Laboratory evaluation is 
normal but there is raised intracranial pressure29.In 
the review of our 3 years experience with 22 patients 
with IIH who underwent Lumboperitoneal shunts , we 
aimed to determine improvement in visual problems 
after surgery. In our study we had age ranged from 18 
to 58 years with mean of 38.and this correlates with 
Whitely and coworkers who prospectively had  peak 
incidence of disease  in 3rd decade of life30.
The disease is more common in women of child bearing 
age. we had all patients female 22(100%) had BIH in 
three years duration. and explanation is consistent with 
the hormonal theory for pathogenesis of  BIH which 
states that high incidence among obese women  as 
adipocytes covert androstenedione to estrone which 
increases CSF production31. Study conducted by 
Yadav YRetal32 also showed this disease in 90.90% 
patients, which closely correlates to our study. 
Headache and vision deterioration are common 
problems in patients with BIH. We had headache in all 
(100%) patients and vision deterioration in 
20(90.90%) patients. It is comparable with study of 
Corbett and colleagues33, who also had  the same 
incidence (100 % of cases) in their series which 
included 20 patients with BIH.  There are many surgical 
treatment options for BIH management which includes 
Lumboperitoneal shunting, Ventriculoperitoneal 
shunting, and optic nerve sheath decompression. 
Cerebrospinal fluid shunting is the most widely 
performed surgical treatment for BIH and it is useful in 
the treatment of Papilledema, headache, and visual 
loss. We did Lumboperitoneal shunting for all(100%) 
patients. Postoperatively headache and Visual 
symptoms improved in 16(72%), and 18(81.81%) 
consecutively. In another international study by Burgett, 
etal34.described an 82% success rate of postoperative 
headache relief and visual improvement in patients 
with LP shunts. So our results are comparable with their 
results. Purvin VA et al35, had studied 30 patients who 
underwent LP shunting for treatment of BIH. Out of 14 
patients with impaired acuity, 10 eyes (71%) improved 
after shunting, which is less as compared to our 81%. 
on subsequent follow up visits 3(13.63%) patients had 
low pressure headache which was conservatively 
managed.
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Background
GullianBarre Syndrome is the most common cause of 
acute flaccid quariparesis.One of the important 
differential of GBS is hypokalemia which is not only 
clinically similar but also gives similar changes in nerve 
conduction studies.We are presenting two cases of 
hyperkalemia which were initially admitted with 
suspicion of GBS but laboratory tests showed 
hyperkalemia.When we did nerve conductionstudies,
changes were very similar to GBS.Moreover, 
electrophysiological changes improved with treatment 
of hyperkalemia.
Case 1
70 years old patient presented in the neurology 
outpatient clinic withprogressive weakness of all four 
limbs for the last 1 week.It was preceded by a diarrheal 
illness that settled spontaneously. Weakness started in 
the legs, and for last 2 days it involved the arms as 
well.She was having mild numbness of arms as well. 
She had normal sphincter control and did not have any 
difficulty in breathing or swallowing. The rest of her 
neurological inquiries likeconsciousness,vision,hearing,
speech,comprehension were normal.Systemic inquiries 
were normal. She was havingdiabetes mellitus and 
hypertension.On examination, she was well oriented 
with normal vital signs. Her cranial nerves examination 
was normal. Power was MRC Grade 4/5 in all four 
limbs.Her reflexes were diminished and planters were 
flexor bilaterally. There was stockings type sensory loss 
in the legs.
Table 1. Baseline investigation (Case1)
She was admitted in the High Dependency area, she 
developed bradycardia,breathing difficulty and was 
intubated and put on ventilator.Immediate nephrology 
consult was sought and hemodialysis started.  Nerve 
conduction studieswere done (Fig 2a) which showed 
acute demyelinating neuropathy probably 
superimposed on background diabetic axonal 
neuropathy. Repeat NCS done 72 hours later showed 
marked improvement (Fig 2b).
Next day the patient improved , she was extubated. 
Serum potassium and sodium repeated after dialysis 
was 4.4 and 131 respectively.She was clinically 
improving and started to walk with support.
Case 2
Forty three years old male, known diabetic for the last 
20 years. He suffered from end stage renal disease and 
was on regular hemodialysis when he missed his 
scheduled dialysis. He presented in emergency 
department with difficulty in getting up from chair.He 
was well before that and was able to walk but for last 3 
days he developed weakness of limbs and was unable 
to get up from chair. He also had a history of 
gastroenteritis 2 days before onset of weakness.He was 
had a family history of diabetes mellitus,hypertension 
and chronic kidney disease.Drug history includes using 
insulin, tab Carvedilol 6.25 mg 1+1,tabHydralazine 
1+1,tab Aspirin 75 QD,Calcium and vitamin D 
supplements.His general physical and systemic 
examination was normal. Power on MRC scale was 5/5 
in upper limbs, it was 3/5 in lower limbs, with absent 
reflexes and flexor plantars. Cranial nerve,sensory 
system and cerebellar examination were normal. The 
patient was admitted in High Depenency unit and 
dialysis started. Patient started to improve as his serum 
potassium was corrected.
Discussion
GullianBarre syndrome is a post-infectious 
polyneuropathy which presents as 
acuteflaccidquariparesis.Low serum potassium level 
can present with weakness mimicking GBS1. 
Hypokalemia is relatively a common disorder causing 
acute flaccid weakness of limbs. In patients presenting 
with acute flaccid quadriparesis, we should check 
serum potassium before making 
diagnosingGullianBarre Syndrome.Hyperkalemia can 
also causeweakness of limbsand is rare cause of 
weakness mimicking GBS.It is an ascending type of 
weakness that ascends upward from legs to arms and 
trunk.Cranial nerves ,sensations and sphincters remain 
intact and respiratory failure is rare2.
Primary hyperkalemic paralysis which is a genetic 
disease of sodium channel is common and usually 
presents in the first decade of life but secondary 
hyperkalemia leading to acute flaccid quadriparesis is 
anuncommon phenomenon3,4.Here we have 
presented two cases ofacute flaccid weaknesswho 
were initially  admitted with a suspicion of GBS but later 
on they were found to have hyperkalemia.
Electrophysiological studies of bothcases showed 
prolonged distal latencies and decreased conduction 
velocities on presentation .In both patients,immediate 
dialysis was done to correct serum potassium and they 
improved.In first patient we repeated studies after 72 
hours and they were significantly improved and some 
axonal neuropathic features were present because of 
underlying diabetic axonal polyneuropathy.In second 
patient studies repeated after 24 hours and they 
showed mild improvement in all parameters. The 
proposed mechanism of hyperkalemia induced 
paralysis is either effect of high potassium on muscle 
fibers and cell membranes orit might be associated 
with neuropathy by high serum potassium level5,6.High 
potassium also inactivates sodium channel and it 
would cause impairment of action potential generation 
and lead to reduced amplitudes of sensorimotor 
nerves7.Impairment of nerve conduction leads to 
prolonged latencies ,conduction blocks and decreased 
conduction velocities8.These changes are reversible as 
evident in our cases and they should be done after 
three days of correction of poatssium as seen in our 
first case where most of nerve conduction changes 
have improvedsignificantly. The changes seen in both 
cases are predominantly demylinating with prolonged 
latencies and decreased conduction velocities and 
some reduction in amplitudes of combined muscle 
action potentials.Hyperkalemia induced weakness is 
very similar to GBS and electrophysiological studies 
may show changes similar to it.Sensory system usually 
remains normal in both hyperkalemic paralysis and 
GBS9,autonomic dysfunction is a feature of GBS and 
not associated with hyperkalemia, however arrhythmias 
may occur due to hyperkalemia10. We suggest that 
Serum potassium must be checked before diagnosing 
GBS as treatment is completely different.
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INTRODUCTION
Benign intracranial hypertension (BIH) or 
pseudotumourcerebri is defined as a syndrome of signs 
and symptoms of increased intracranial pressure 
without clinical, laboratory or radiologic evidence of 
causative lesions on magnetic resonance imaging 
(MRI) or computed tomography1.  BIH occurs most 
commonly in obese women of reproductive age. The 
incidence is approximately 1/100 000/year rising to 
13/100 000/ year in women who are 10% above ideal 
body weight  between 20 and 44 years. BIH less 
frequently seen in males and children.Prevalence rates 
are higher, showing the chronic nature of the condition 
in majority cases2,3,4,5. Average age at the time of 
diagnosis Benign intracranial Hypertension  is 30 
years6. Some medications  such as steroid withdrawal, 
lithium, tetracycline’s, and vitamin analogs and 
systemic conditions  such as  obstructive sleep apnea, 
renal failure, coagulopathies, and anemia have also 
been associated with BIH6,7,8. Cerebral venous 
hypertension due to  Dural venous sinus thrombosis, 
neoplastic obstruction of siuses or a duralarteriovenous 
malformation causes a very similar clinical picture and 
diagnosis of BIH is made when cerebral venous 
obstruction and other causes of raised intracranial 
pressure have been ruled out on Neuroimaging9.The 
symptoms of BIH patients are headache (94%), 
transient visual obscurations (68%), pulse-synchronous 
tinnitus (58%), photopsia (54%), and retrobulbar pain 
(44%). Diplopia (38%) and visual loss (30%) are less 
commonly  features of BIH10. To diagnose BIH we 
should have (1) Raised intracranial pressure; (2) 
Normal neurologic examination except  Papilledema 
and an occasionally abducens nerve palsy (3) the 
absence of a space-occupying lesion, or ventricular 
enlargement on computed tomography or magnetic 
resonance imaging; and (4) a normal cerebrospinal 
fluid composition10,11,12.In addition to these 
features CSF manometery is of diagnostic and 
therapeutic importance. CSF  opening pressure greater 
than 250 mm H2O is diagnostic, less than 200 mm 
H2O is normal, and 201 to 249 mm H2O is 
nondiagnostic13.Management  aim is controlling 
symptoms of raised intracranial pressure (ICP) and 
prevention of loss of vision due to Papilledema.Dietary 
modification and weight loss are time part of initial 
managment14,15 , Repeated  lumber puncture are 
sometimes used in patients to control symptom , in 
pregnant women, or in the setting of rapidly declining 
vision to temporarily lower16 and optimize  the CSF 
pressure. Acetazolamide  a carbonic anhydrase 
inhibitor is used  for lowering the intracranial 
hypertension by decreasing CSF production (Doses of 1 
to 2 g ).Surgical treatment is indicated in cases with 
failed medical treatment or rapidly deteriorating vision. 
Generally, the indication for a CSF diversion procedure 
is failed medical treatment or intractable headache17. 
There are many surgical treatment options like 
lumboperitoneal shunt18,19,20 optic nerve sheath 
fenestration21,22, ventriculoperitoneal (VP) 
shunt23,24,25and venous sinus stenting for patients 
of BIH26,27 . Currently Lumboperitoneal shunt is most 
commonly advised to patients of BIH. As vision 
deterioration and headache are the  most common 
presenting and disabling feature of patients with BIH, 
therefore we conducted this study to determine 
outcome of lumboperitoneal shunt in patients with BIH 
in terms of improvement in vision..
Material and methods
We conducted  this Prospective observational  study of 
22 patients operated in neurosurgery unit lady reading 
hospital Peshawar   from Jan 2011 to Jun2014. 
Written consent was obtained from all the patients or 
their relatives All patients of either age and  sex with 
Diagnosed cases of  BIH were included in the study, 
Patients with depressed conscious level, Malignant 
hypertension, Patients with space occupying lesion in 
brain on MRI, Patients unfit for surgery and unwilling for 
surgery were excluded from the study.Pre operative 
funds examination and visual field charting was done in 
all the cases. Pre-operatively CT scan /MRI brain was 
done in all the patients. MR venography was also done 
in all patients.  Cerebrospinal fluid examination was 
performed in all patients. All patients were admitted 
through OPD in ward. Preoperative work up was done in 
all cases. Hematologic tests like FBC,Urea,RBS, and 
Serologic tests like HBS and HCV were done for all 
cases. Lumboperitoneal shunt was done in all cases 
under G.A.
TECHNIQUE OF SURGERY
Position;Lateral decubitus position with both knee 
flexed.
Skin incision: 
1.5 to 2 cm at L3-L4 or L4-L5 level extended down to 
the lumber fascia overlying the spinous processes.  Tilt 
table to 30 degree Reverse Trendelenburg to Increase 
lumbar subarachnoid space. Then Insertion of 
14-gauge Tuohy needle in interspinous space to reach 
into the subarachnoid space, with opening directed 
rostrally. Removal of the trocar with insertion of shunt 
tube ( 8 to 10 cm).stabilization of catheter at back 
wound under lumber fascia with reservoir . 
Abdominal placement: 
Incision is made into anterior abdominal wall, extended 
down and peritoneum is opened. Then subcutaneous 
shunt passer is passed and redirected to back incision. 
shunt catheter stabilized with reservoir at back incision 
is passed through passer, and inserted into peritoneal 
cavity. the wound is then closed.After surgery all 
patients were kept in ward for 4 to 5 days and then 
discharged to home. All patients were followed up till 1 
year, with 2 months interval.Postoperatively clinical 
outcome was measured by History and Fundus 
examination and CT brain. Postoperative follow up was 
clinical with history and Fundoscopy, and radiological 
with CT brain.All data was collected and put in 
Performa. All data was analyzed using SPSS version 
20. Results were expressed in the form of 
tables/graphs/charts.
Results
We studied 22 patients with Diagnosed cases of BIH. 
All patients were female. Age ranged from 18 to 58 
with mean of 38 ± 5 years SD.  In pre operative signs 
and symptoms the commonest was headache which 
was present in all (100%) patients , Visual 
deterioration in 20(90.90%) patient and all (100 %) 
these patients had Papilledema. 6(27.7%) patients 
had vomiting , 6th nerve palsy in  2(9.09%) patients 
(Table no 1) . All patients were investigated to follow 
modified dandy criteria.  CT brain was done in 
10(45.45%) patients. MRI brain with MRV was done in 
all( 100%) patients. CSF manometery showed opening 
pressure from 28cm of H2O to 50 cm of H2O, with 
mean of 39.19. CSF composition was normal in all 
patients. MRI brain showed slit ventricles in 3(13.63%) 
cases. LP shunt was done for all 22(100%) cases. 
Postoperatively clinical outcome was measured by 
History and Fundus examination and CT brain uptill 1 
years by intervals of 2 months follow up. Headache 
improved in 16(72%) patients, Papilledema resolved 
postoperatively in 18(81.81%) cases and same 
number of patients 18(81.81%) showed improvement 
in vision.  4(18%) patients had persistence of 
symptoms postoperatively. Shunt infection was noticed 
in 2(9.09%) cases in first 4 weeks which was 
subsequently managed.  CSF leak was noticed in 
1(4.54%) case for which shunt revision was done 
(Graph no 1).
Table no 1; Pre operative signs and symptoms N=22
 
Graph no 1; Post operative outcome of BIH N=22
Discussion
Benign intracranial hypertension is characterized by 
Raised CSF pressure of unknown Reason. Resistance 
to  CSF outflow  appears to increase, so intracranial 
pressure also increases. Whether the increased 
resisance is due to outflow which is  obstructed at the 
level of the arachnoid granulations or outer lymphatic’s 
flow is unclear ,however BIH can result in blindness if 
inadequately treated but  effective options strategies 
are available 28.The initial criteria suggested by Walter 
Dandy have been modified now called modified dandy 
criteria. Patients who follow these criteria are 
diagnosed as having the BIH. Laboratory evaluation is 
normal but there is raised intracranial pressure29.In 
the review of our 3 years experience with 22 patients 
with IIH who underwent Lumboperitoneal shunts , we 
aimed to determine improvement in visual problems 
after surgery. In our study we had age ranged from 18 
to 58 years with mean of 38.and this correlates with 
Whitely and coworkers who prospectively had  peak 
incidence of disease  in 3rd decade of life30.
The disease is more common in women of child bearing 
age. we had all patients female 22(100%) had BIH in 
three years duration. and explanation is consistent with 
the hormonal theory for pathogenesis of  BIH which 
states that high incidence among obese women  as 
adipocytes covert androstenedione to estrone which 
increases CSF production31. Study conducted by 
Yadav YRetal32 also showed this disease in 90.90% 
patients, which closely correlates to our study. 
Headache and vision deterioration are common 
problems in patients with BIH. We had headache in all 
(100%) patients and vision deterioration in 
20(90.90%) patients. It is comparable with study of 
Corbett and colleagues33, who also had  the same 
incidence (100 % of cases) in their series which 
included 20 patients with BIH.  There are many surgical 
treatment options for BIH management which includes 
Lumboperitoneal shunting, Ventriculoperitoneal 
shunting, and optic nerve sheath decompression. 
Cerebrospinal fluid shunting is the most widely 
performed surgical treatment for BIH and it is useful in 
the treatment of Papilledema, headache, and visual 
loss. We did Lumboperitoneal shunting for all(100%) 
patients. Postoperatively headache and Visual 
symptoms improved in 16(72%), and 18(81.81%) 
consecutively. In another international study by Burgett, 
etal34.described an 82% success rate of postoperative 
headache relief and visual improvement in patients 
with LP shunts. So our results are comparable with their 
results. Purvin VA et al35, had studied 30 patients who 
underwent LP shunting for treatment of BIH. Out of 14 
patients with impaired acuity, 10 eyes (71%) improved 
after shunting, which is less as compared to our 81%. 
on subsequent follow up visits 3(13.63%) patients had 
low pressure headache which was conservatively 
managed.
References
1.  Digre KB, Corbett JJ. Idiopathic intracranial
 hypertension ( pseudotumor cerebri): a
Pre operative signs  
and symptoms  
No of patients  Percentage
of patients 
 
Headache  
 
22 100%  
 
Papilledema 
 
22 100 % 
 
Visual  deterioration  
 
20  
 
90.90% 
vomiting  6 27.7% 
 6th nerve palsy   2 9.09% 
 
 reappraisal. Neurologist . 2001;7:2–67.
2. Radhakrishnan K, Ahlskog JE, Cross SA, Kurland
 LT, O Fallon WM. Idiopathic intracranial 
 hypertension (pseudotumor cerebri). Descriptive 
 epidemiology in Rochester, Minn, 1976 to 
 1990.Arch Neurol. 1993;50:78–80.
3.  Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo 
 JC, Gerryo SE. Epidemiology of idiopathic 
 intracranial hypertension: a prospective and 
 case–control study. J Neurol Sci. 
 1993;116:18–28.
4.  Durcan FJ, Corbett JJ, Wall M. The incidence of
 pseudotumor cerebri: population studies in Iowa 
 and Louisiana. Arch Neurol. 1988;45:875–7.
5.  Gordon K. Pediatric pseudotumor cerebri: 
 descriptive epidemiology. Can J Neurol Sci. 
 1997;24:219–21.
6.  Durcan FJ, Corbett JJ, Wall M.The incidence of 
 pseudotumor cerebri. Population studies in Iowa 
 and Louisiana.Arch Neurol. 1988;45:875–7.
7.  Shaw GY, Million SK. Benign intracranial 
 hypertension: A diagnostic dilemma. Case Rep 
 Otolaryngol. 2012;2012:814.
8.  Binder DK, Horton JC, Lawton MT, McDermottMW. 
 Idiopathic intracranial hypertension.Neurosurg. 
 2004;54:538 51.
9.  Biousse V, Bousser MG. Benign intracranial 
 hypertension. Rev Neurol. 2001;157:21–34.
10. Wall M.The headache profie of idiopathic
 intracranialhypertension.Cephalalgia.1990;
 1 0 : 3 3 1 – 5 .
11.  Ahlskog JE, O'Neill BP. Pseudotumor cerebri. Ann 
 Intern Med. 1982;97:249-56.
12.  Smith JL. Whence pseudotumor cerebri? J Clin 
 Neuro-Ophthalmol. 1985;5:55-6.
13.  Corbett JJ, Mehta MP. Cerebrospinal fluid pressure 
 in normal obese subjects and patients with 
 pseudotumor cerebri.Neurology.1983;33:
 1386–8.
14. Newborg B. Pseudotumor cerebri treated by 
 rice/reduction diet.Arch Intern 
 Med.1974;133:802–7.
15.  Friedman DI, Ingram P, Rogers MAM. Low tyramine 
 diet in the treatment of idiopathic intracranial 
 hypertension: a pilot study. Neurology.
 1998;50:45-8.
16. Corbett JJ, Thompson HS. The rational 
 management of idiopathic intracranial 
 hypertension.Arch Neurol,1989;46:1049–51.
17. Physicians’ Desk Reference, 56th edition. 
 Montvale, NJ: Medical Economics Company, Inc; 
 2002:2590–5.
18.  Garton HJ.Cerebrospinal flid diversion 
 procedures.J Neuroophthalmol.2004;24(2):
 146-55.
19.  Kesler A, Gadoth N. Pseudotumor cerebri 
 (PTC--an update). Harefuah.2002;141(3):
 297-300.
20.  Liu GT, Volpe NJ, Schatz NJ, Galetta SL, Farrar JT, 
 Raps EC. Severe sudden visual loss caused by 
 pseudotumor cerebri and lumboperitoneal shunt
 failure. Am J Ophthalmol.1996;122(1):
 129-131.
21.  Brazis PW: Clinical review: The surgical treatment 
 of idiopathic pseudotumour cerebri (idiopathic 
 intracranial hypertension. Cephalalgia.2008;
 28(12):1361-73.
22. Feldon SE. Visual outcomes comparing surgical 
 techniques for management of severe idiopathic 
 intracranial hypertension.Neurosurg Focus.
 2007;23(5):43-6.
23.  Sergott RC, Savino PJ, Bosley TM. Optic nerve 
 sheath decompression: A clinical review and
 proposed pathophysiologic mechanism. Aust N Z J 
 Ophthalmol.1990;18(4):365-73.
24.  Villain MA, Candon E, Arnaud B, Hamard H,
 Adenis JP. Optic nerve sheath decompression in 
 optic neuropathy complicating idiopathic 
 intracranial hypertension: A new focus. J Fr 
 Ophtalmol.2003;26(2):191-7.
25.  Woodworth GF, McGirt MJ, Elfert P, Sciubba DM,
 Rigamonti D. Frameless stereotactic ventricular 
 shunt placement for idiopathic intracranial 
 hypertension. Stereotact Funct Neurosurg.
 2005;83(1):12-6.
26. Brazis PW.Pseudotumor cerebri.Curr Neurol
 Neurosci Rep.2004;4(2):111-6.
27.  Brazis PW. Clinical review: The surgical treatment 
 of idiopathic pseudotumour cerebri (idiopathic
 intracranial hypertension. Cephalalgia.2008;
 28(12):1361-73.
28. Friedman DI, Jacobobson DM. Idiopathic
 intracranial hypertension. J Neurol
 Ophthalmol.2004;24:139-45.
29. Vitale S, Eggenberger ER, Miller NR.
 Lumboperitoneal shunt for the treatment of
 pseudotumor cerebri. Neurology.1996;46:
 1524–30.
30.  Whiteley W., Al Shahi R. CSF opening pressure: 
 Reference interval and the effect
 of body mass index. Neurology.2006;67(9):
 1690-3.
31.  Binder DK, Horton JC, Lawton MT. Idiopathic
 intracranial hypertension. Neurosurg.2004;5
 (3):538–51.
32.  Yadav  RM. lumbar Peritoneal Shunt in idiopathic
 IntracranialHypertension" Turkish Neurosurg.
 2012;22(1):21-6.
33.  Corbett JJ, Mehta MP.Cerebrospinal fluid pressure 
 in normal obese subjects and patients with 
 pseudotumor cerebri.Neurology.1983;33:
 1386–8.
34. Burgett RA, Purvin VA, Kawasaki A. 
 Lumboperitoneal shunting for pseudotumor 
 cerebri. Neurology.1997;49:734–9.
35. Purvin VA, Burgett RA, Kawasaki A.
 Lumboperitoneal shunting for pseudotumor 
 cerebri. Neurology.1997;49:734–9.
Background
GullianBarre Syndrome is the most common cause of 
acute flaccid quariparesis.One of the important 
differential of GBS is hypokalemia which is not only 
clinically similar but also gives similar changes in nerve 
conduction studies.We are presenting two cases of 
hyperkalemia which were initially admitted with 
suspicion of GBS but laboratory tests showed 
hyperkalemia.When we did nerve conductionstudies,
changes were very similar to GBS.Moreover, 
electrophysiological changes improved with treatment 
of hyperkalemia.
Case 1
70 years old patient presented in the neurology 
outpatient clinic withprogressive weakness of all four 
limbs for the last 1 week.It was preceded by a diarrheal 
illness that settled spontaneously. Weakness started in 
the legs, and for last 2 days it involved the arms as 
well.She was having mild numbness of arms as well. 
She had normal sphincter control and did not have any 
difficulty in breathing or swallowing. The rest of her 
neurological inquiries likeconsciousness,vision,hearing,
speech,comprehension were normal.Systemic inquiries 
were normal. She was havingdiabetes mellitus and 
hypertension.On examination, she was well oriented 
with normal vital signs. Her cranial nerves examination 
was normal. Power was MRC Grade 4/5 in all four 
limbs.Her reflexes were diminished and planters were 
flexor bilaterally. There was stockings type sensory loss 
in the legs.
Table 1. Baseline investigation (Case1)
She was admitted in the High Dependency area, she 
developed bradycardia,breathing difficulty and was 
intubated and put on ventilator.Immediate nephrology 
consult was sought and hemodialysis started.  Nerve 
conduction studieswere done (Fig 2a) which showed 
acute demyelinating neuropathy probably 
superimposed on background diabetic axonal 
neuropathy. Repeat NCS done 72 hours later showed 
marked improvement (Fig 2b).
Next day the patient improved , she was extubated. 
Serum potassium and sodium repeated after dialysis 
was 4.4 and 131 respectively.She was clinically 
improving and started to walk with support.
Case 2
Forty three years old male, known diabetic for the last 
20 years. He suffered from end stage renal disease and 
was on regular hemodialysis when he missed his 
scheduled dialysis. He presented in emergency 
department with difficulty in getting up from chair.He 
was well before that and was able to walk but for last 3 
days he developed weakness of limbs and was unable 
to get up from chair. He also had a history of 
gastroenteritis 2 days before onset of weakness.He was 
had a family history of diabetes mellitus,hypertension 
and chronic kidney disease.Drug history includes using 
insulin, tab Carvedilol 6.25 mg 1+1,tabHydralazine 
1+1,tab Aspirin 75 QD,Calcium and vitamin D 
supplements.His general physical and systemic 
examination was normal. Power on MRC scale was 5/5 
in upper limbs, it was 3/5 in lower limbs, with absent 
reflexes and flexor plantars. Cranial nerve,sensory 
system and cerebellar examination were normal. The 
patient was admitted in High Depenency unit and 
dialysis started. Patient started to improve as his serum 
potassium was corrected.
Discussion
GullianBarre syndrome is a post-infectious 
polyneuropathy which presents as 
acuteflaccidquariparesis.Low serum potassium level 
can present with weakness mimicking GBS1. 
Hypokalemia is relatively a common disorder causing 
acute flaccid weakness of limbs. In patients presenting 
with acute flaccid quadriparesis, we should check 
serum potassium before making 
diagnosingGullianBarre Syndrome.Hyperkalemia can 
also causeweakness of limbsand is rare cause of 
weakness mimicking GBS.It is an ascending type of 
weakness that ascends upward from legs to arms and 
trunk.Cranial nerves ,sensations and sphincters remain 
intact and respiratory failure is rare2.
Primary hyperkalemic paralysis which is a genetic 
disease of sodium channel is common and usually 
presents in the first decade of life but secondary 
hyperkalemia leading to acute flaccid quadriparesis is 
anuncommon phenomenon3,4.Here we have 
presented two cases ofacute flaccid weaknesswho 
were initially  admitted with a suspicion of GBS but later 
on they were found to have hyperkalemia.
Electrophysiological studies of bothcases showed 
prolonged distal latencies and decreased conduction 
velocities on presentation .In both patients,immediate 
dialysis was done to correct serum potassium and they 
improved.In first patient we repeated studies after 72 
hours and they were significantly improved and some 
axonal neuropathic features were present because of 
underlying diabetic axonal polyneuropathy.In second 
patient studies repeated after 24 hours and they 
showed mild improvement in all parameters. The 
proposed mechanism of hyperkalemia induced 
paralysis is either effect of high potassium on muscle 
fibers and cell membranes orit might be associated 
with neuropathy by high serum potassium level5,6.High 
potassium also inactivates sodium channel and it 
would cause impairment of action potential generation 
and lead to reduced amplitudes of sensorimotor 
nerves7.Impairment of nerve conduction leads to 
prolonged latencies ,conduction blocks and decreased 
conduction velocities8.These changes are reversible as 
evident in our cases and they should be done after 
three days of correction of poatssium as seen in our 
first case where most of nerve conduction changes 
have improvedsignificantly. The changes seen in both 
cases are predominantly demylinating with prolonged 
latencies and decreased conduction velocities and 
some reduction in amplitudes of combined muscle 
action potentials.Hyperkalemia induced weakness is 
very similar to GBS and electrophysiological studies 
may show changes similar to it.Sensory system usually 
remains normal in both hyperkalemic paralysis and 
GBS9,autonomic dysfunction is a feature of GBS and 
not associated with hyperkalemia, however arrhythmias 
may occur due to hyperkalemia10. We suggest that 
Serum potassium must be checked before diagnosing 
GBS as treatment is completely different.
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INTRODUCTION
Benign intracranial hypertension (BIH) or 
pseudotumourcerebri is defined as a syndrome of signs 
and symptoms of increased intracranial pressure 
without clinical, laboratory or radiologic evidence of 
causative lesions on magnetic resonance imaging 
(MRI) or computed tomography1.  BIH occurs most 
commonly in obese women of reproductive age. The 
incidence is approximately 1/100 000/year rising to 
13/100 000/ year in women who are 10% above ideal 
body weight  between 20 and 44 years. BIH less 
frequently seen in males and children.Prevalence rates 
are higher, showing the chronic nature of the condition 
in majority cases2,3,4,5. Average age at the time of 
diagnosis Benign intracranial Hypertension  is 30 
years6. Some medications  such as steroid withdrawal, 
lithium, tetracycline’s, and vitamin analogs and 
systemic conditions  such as  obstructive sleep apnea, 
renal failure, coagulopathies, and anemia have also 
been associated with BIH6,7,8. Cerebral venous 
hypertension due to  Dural venous sinus thrombosis, 
neoplastic obstruction of siuses or a duralarteriovenous 
malformation causes a very similar clinical picture and 
diagnosis of BIH is made when cerebral venous 
obstruction and other causes of raised intracranial 
pressure have been ruled out on Neuroimaging9.The 
symptoms of BIH patients are headache (94%), 
transient visual obscurations (68%), pulse-synchronous 
tinnitus (58%), photopsia (54%), and retrobulbar pain 
(44%). Diplopia (38%) and visual loss (30%) are less 
commonly  features of BIH10. To diagnose BIH we 
should have (1) Raised intracranial pressure; (2) 
Normal neurologic examination except  Papilledema 
and an occasionally abducens nerve palsy (3) the 
absence of a space-occupying lesion, or ventricular 
enlargement on computed tomography or magnetic 
resonance imaging; and (4) a normal cerebrospinal 
fluid composition10,11,12.In addition to these 
features CSF manometery is of diagnostic and 
therapeutic importance. CSF  opening pressure greater 
than 250 mm H2O is diagnostic, less than 200 mm 
H2O is normal, and 201 to 249 mm H2O is 
nondiagnostic13.Management  aim is controlling 
symptoms of raised intracranial pressure (ICP) and 
prevention of loss of vision due to Papilledema.Dietary 
modification and weight loss are time part of initial 
managment14,15 , Repeated  lumber puncture are 
sometimes used in patients to control symptom , in 
pregnant women, or in the setting of rapidly declining 
vision to temporarily lower16 and optimize  the CSF 
pressure. Acetazolamide  a carbonic anhydrase 
inhibitor is used  for lowering the intracranial 
hypertension by decreasing CSF production (Doses of 1 
to 2 g ).Surgical treatment is indicated in cases with 
failed medical treatment or rapidly deteriorating vision. 
Generally, the indication for a CSF diversion procedure 
is failed medical treatment or intractable headache17. 
There are many surgical treatment options like 
lumboperitoneal shunt18,19,20 optic nerve sheath 
fenestration21,22, ventriculoperitoneal (VP) 
shunt23,24,25and venous sinus stenting for patients 
of BIH26,27 . Currently Lumboperitoneal shunt is most 
commonly advised to patients of BIH. As vision 
deterioration and headache are the  most common 
presenting and disabling feature of patients with BIH, 
therefore we conducted this study to determine 
outcome of lumboperitoneal shunt in patients with BIH 
in terms of improvement in vision..
Material and methods
We conducted  this Prospective observational  study of 
22 patients operated in neurosurgery unit lady reading 
hospital Peshawar   from Jan 2011 to Jun2014. 
Written consent was obtained from all the patients or 
their relatives All patients of either age and  sex with 
Diagnosed cases of  BIH were included in the study, 
Patients with depressed conscious level, Malignant 
hypertension, Patients with space occupying lesion in 
brain on MRI, Patients unfit for surgery and unwilling for 
surgery were excluded from the study.Pre operative 
funds examination and visual field charting was done in 
all the cases. Pre-operatively CT scan /MRI brain was 
done in all the patients. MR venography was also done 
in all patients.  Cerebrospinal fluid examination was 
performed in all patients. All patients were admitted 
through OPD in ward. Preoperative work up was done in 
all cases. Hematologic tests like FBC,Urea,RBS, and 
Serologic tests like HBS and HCV were done for all 
cases. Lumboperitoneal shunt was done in all cases 
under G.A.
TECHNIQUE OF SURGERY
Position;Lateral decubitus position with both knee 
flexed.
Skin incision: 
1.5 to 2 cm at L3-L4 or L4-L5 level extended down to 
the lumber fascia overlying the spinous processes.  Tilt 
table to 30 degree Reverse Trendelenburg to Increase 
lumbar subarachnoid space. Then Insertion of 
14-gauge Tuohy needle in interspinous space to reach 
into the subarachnoid space, with opening directed 
rostrally. Removal of the trocar with insertion of shunt 
tube ( 8 to 10 cm).stabilization of catheter at back 
wound under lumber fascia with reservoir . 
Abdominal placement: 
Incision is made into anterior abdominal wall, extended 
down and peritoneum is opened. Then subcutaneous 
shunt passer is passed and redirected to back incision. 
shunt catheter stabilized with reservoir at back incision 
is passed through passer, and inserted into peritoneal 
cavity. the wound is then closed.After surgery all 
patients were kept in ward for 4 to 5 days and then 
discharged to home. All patients were followed up till 1 
year, with 2 months interval.Postoperatively clinical 
outcome was measured by History and Fundus 
examination and CT brain. Postoperative follow up was 
clinical with history and Fundoscopy, and radiological 
with CT brain.All data was collected and put in 
Performa. All data was analyzed using SPSS version 
20. Results were expressed in the form of 
tables/graphs/charts.
Results
We studied 22 patients with Diagnosed cases of BIH. 
All patients were female. Age ranged from 18 to 58 
with mean of 38 ± 5 years SD.  In pre operative signs 
and symptoms the commonest was headache which 
was present in all (100%) patients , Visual 
deterioration in 20(90.90%) patient and all (100 %) 
these patients had Papilledema. 6(27.7%) patients 
had vomiting , 6th nerve palsy in  2(9.09%) patients 
(Table no 1) . All patients were investigated to follow 
modified dandy criteria.  CT brain was done in 
10(45.45%) patients. MRI brain with MRV was done in 
all( 100%) patients. CSF manometery showed opening 
pressure from 28cm of H2O to 50 cm of H2O, with 
mean of 39.19. CSF composition was normal in all 
patients. MRI brain showed slit ventricles in 3(13.63%) 
cases. LP shunt was done for all 22(100%) cases. 
Postoperatively clinical outcome was measured by 
History and Fundus examination and CT brain uptill 1 
years by intervals of 2 months follow up. Headache 
improved in 16(72%) patients, Papilledema resolved 
postoperatively in 18(81.81%) cases and same 
number of patients 18(81.81%) showed improvement 
in vision.  4(18%) patients had persistence of 
symptoms postoperatively. Shunt infection was noticed 
in 2(9.09%) cases in first 4 weeks which was 
subsequently managed.  CSF leak was noticed in 
1(4.54%) case for which shunt revision was done 
(Graph no 1).
Table no 1; Pre operative signs and symptoms N=22
 
Graph no 1; Post operative outcome of BIH N=22
Discussion
Benign intracranial hypertension is characterized by 
Raised CSF pressure of unknown Reason. Resistance 
to  CSF outflow  appears to increase, so intracranial 
pressure also increases. Whether the increased 
resisance is due to outflow which is  obstructed at the 
level of the arachnoid granulations or outer lymphatic’s 
flow is unclear ,however BIH can result in blindness if 
inadequately treated but  effective options strategies 
are available 28.The initial criteria suggested by Walter 
Dandy have been modified now called modified dandy 
criteria. Patients who follow these criteria are 
diagnosed as having the BIH. Laboratory evaluation is 
normal but there is raised intracranial pressure29.In 
the review of our 3 years experience with 22 patients 
with IIH who underwent Lumboperitoneal shunts , we 
aimed to determine improvement in visual problems 
after surgery. In our study we had age ranged from 18 
to 58 years with mean of 38.and this correlates with 
Whitely and coworkers who prospectively had  peak 
incidence of disease  in 3rd decade of life30.
The disease is more common in women of child bearing 
age. we had all patients female 22(100%) had BIH in 
three years duration. and explanation is consistent with 
the hormonal theory for pathogenesis of  BIH which 
states that high incidence among obese women  as 
adipocytes covert androstenedione to estrone which 
increases CSF production31. Study conducted by 
Yadav YRetal32 also showed this disease in 90.90% 
patients, which closely correlates to our study. 
Headache and vision deterioration are common 
problems in patients with BIH. We had headache in all 
(100%) patients and vision deterioration in 
20(90.90%) patients. It is comparable with study of 
Corbett and colleagues33, who also had  the same 
incidence (100 % of cases) in their series which 
included 20 patients with BIH.  There are many surgical 
treatment options for BIH management which includes 
Lumboperitoneal shunting, Ventriculoperitoneal 
shunting, and optic nerve sheath decompression. 
Cerebrospinal fluid shunting is the most widely 
performed surgical treatment for BIH and it is useful in 
the treatment of Papilledema, headache, and visual 
loss. We did Lumboperitoneal shunting for all(100%) 
patients. Postoperatively headache and Visual 
symptoms improved in 16(72%), and 18(81.81%) 
consecutively. In another international study by Burgett, 
etal34.described an 82% success rate of postoperative 
headache relief and visual improvement in patients 
with LP shunts. So our results are comparable with their 
results. Purvin VA et al35, had studied 30 patients who 
underwent LP shunting for treatment of BIH. Out of 14 
patients with impaired acuity, 10 eyes (71%) improved 
after shunting, which is less as compared to our 81%. 
on subsequent follow up visits 3(13.63%) patients had 
low pressure headache which was conservatively 
managed.
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Background
GullianBarre Syndrome is the most common cause of 
acute flaccid quariparesis.One of the important 
differential of GBS is hypokalemia which is not only 
clinically similar but also gives similar changes in nerve 
conduction studies.We are presenting two cases of 
hyperkalemia which were initially admitted with 
suspicion of GBS but laboratory tests showed 
hyperkalemia.When we did nerve conductionstudies,
changes were very similar to GBS.Moreover, 
electrophysiological changes improved with treatment 
of hyperkalemia.
Case 1
70 years old patient presented in the neurology 
outpatient clinic withprogressive weakness of all four 
limbs for the last 1 week.It was preceded by a diarrheal 
illness that settled spontaneously. Weakness started in 
the legs, and for last 2 days it involved the arms as 
well.She was having mild numbness of arms as well. 
She had normal sphincter control and did not have any 
difficulty in breathing or swallowing. The rest of her 
neurological inquiries likeconsciousness,vision,hearing,
speech,comprehension were normal.Systemic inquiries 
were normal. She was havingdiabetes mellitus and 
hypertension.On examination, she was well oriented 
with normal vital signs. Her cranial nerves examination 
was normal. Power was MRC Grade 4/5 in all four 
limbs.Her reflexes were diminished and planters were 
flexor bilaterally. There was stockings type sensory loss 
in the legs.
Table 1. Baseline investigation (Case1)
She was admitted in the High Dependency area, she 
developed bradycardia,breathing difficulty and was 
intubated and put on ventilator.Immediate nephrology 
consult was sought and hemodialysis started.  Nerve 
conduction studieswere done (Fig 2a) which showed 
acute demyelinating neuropathy probably 
superimposed on background diabetic axonal 
neuropathy. Repeat NCS done 72 hours later showed 
marked improvement (Fig 2b).
Next day the patient improved , she was extubated. 
Serum potassium and sodium repeated after dialysis 
was 4.4 and 131 respectively.She was clinically 
improving and started to walk with support.
Case 2
Forty three years old male, known diabetic for the last 
20 years. He suffered from end stage renal disease and 
was on regular hemodialysis when he missed his 
scheduled dialysis. He presented in emergency 
department with difficulty in getting up from chair.He 
was well before that and was able to walk but for last 3 
days he developed weakness of limbs and was unable 
to get up from chair. He also had a history of 
gastroenteritis 2 days before onset of weakness.He was 
had a family history of diabetes mellitus,hypertension 
and chronic kidney disease.Drug history includes using 
insulin, tab Carvedilol 6.25 mg 1+1,tabHydralazine 
1+1,tab Aspirin 75 QD,Calcium and vitamin D 
supplements.His general physical and systemic 
examination was normal. Power on MRC scale was 5/5 
in upper limbs, it was 3/5 in lower limbs, with absent 
reflexes and flexor plantars. Cranial nerve,sensory 
system and cerebellar examination were normal. The 
patient was admitted in High Depenency unit and 
dialysis started. Patient started to improve as his serum 
potassium was corrected.
Discussion
GullianBarre syndrome is a post-infectious 
polyneuropathy which presents as 
acuteflaccidquariparesis.Low serum potassium level 
can present with weakness mimicking GBS1. 
Hypokalemia is relatively a common disorder causing 
acute flaccid weakness of limbs. In patients presenting 
with acute flaccid quadriparesis, we should check 
serum potassium before making 
diagnosingGullianBarre Syndrome.Hyperkalemia can 
also causeweakness of limbsand is rare cause of 
weakness mimicking GBS.It is an ascending type of 
weakness that ascends upward from legs to arms and 
trunk.Cranial nerves ,sensations and sphincters remain 
intact and respiratory failure is rare2.
Primary hyperkalemic paralysis which is a genetic 
disease of sodium channel is common and usually 
presents in the first decade of life but secondary 
hyperkalemia leading to acute flaccid quadriparesis is 
anuncommon phenomenon3,4.Here we have 
presented two cases ofacute flaccid weaknesswho 
were initially  admitted with a suspicion of GBS but later 
on they were found to have hyperkalemia.
Electrophysiological studies of bothcases showed 
prolonged distal latencies and decreased conduction 
velocities on presentation .In both patients,immediate 
dialysis was done to correct serum potassium and they 
improved.In first patient we repeated studies after 72 
hours and they were significantly improved and some 
axonal neuropathic features were present because of 
underlying diabetic axonal polyneuropathy.In second 
patient studies repeated after 24 hours and they 
showed mild improvement in all parameters. The 
proposed mechanism of hyperkalemia induced 
paralysis is either effect of high potassium on muscle 
fibers and cell membranes orit might be associated 
with neuropathy by high serum potassium level5,6.High 
potassium also inactivates sodium channel and it 
would cause impairment of action potential generation 
and lead to reduced amplitudes of sensorimotor 
nerves7.Impairment of nerve conduction leads to 
prolonged latencies ,conduction blocks and decreased 
conduction velocities8.These changes are reversible as 
evident in our cases and they should be done after 
three days of correction of poatssium as seen in our 
first case where most of nerve conduction changes 
have improvedsignificantly. The changes seen in both 
cases are predominantly demylinating with prolonged 
latencies and decreased conduction velocities and 
some reduction in amplitudes of combined muscle 
action potentials.Hyperkalemia induced weakness is 
very similar to GBS and electrophysiological studies 
may show changes similar to it.Sensory system usually 
remains normal in both hyperkalemic paralysis and 
GBS9,autonomic dysfunction is a feature of GBS and 
not associated with hyperkalemia, however arrhythmias 
may occur due to hyperkalemia10. We suggest that 
Serum potassium must be checked before diagnosing 
GBS as treatment is completely different.
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INTRODUCTION
Benign intracranial hypertension (BIH) or 
pseudotumourcerebri is defined as a syndrome of signs 
and symptoms of increased intracranial pressure 
without clinical, laboratory or radiologic evidence of 
causative lesions on magnetic resonance imaging 
(MRI) or computed tomography1.  BIH occurs most 
commonly in obese women of reproductive age. The 
incidence is approximately 1/100 000/year rising to 
13/100 000/ year in women who are 10% above ideal 
body weight  between 20 and 44 years. BIH less 
frequently seen in males and children.Prevalence rates 
are higher, showing the chronic nature of the condition 
in majority cases2,3,4,5. Average age at the time of 
diagnosis Benign intracranial Hypertension  is 30 
years6. Some medications  such as steroid withdrawal, 
lithium, tetracycline’s, and vitamin analogs and 
systemic conditions  such as  obstructive sleep apnea, 
renal failure, coagulopathies, and anemia have also 
been associated with BIH6,7,8. Cerebral venous 
hypertension due to  Dural venous sinus thrombosis, 
neoplastic obstruction of siuses or a duralarteriovenous 
malformation causes a very similar clinical picture and 
diagnosis of BIH is made when cerebral venous 
obstruction and other causes of raised intracranial 
pressure have been ruled out on Neuroimaging9.The 
symptoms of BIH patients are headache (94%), 
transient visual obscurations (68%), pulse-synchronous 
tinnitus (58%), photopsia (54%), and retrobulbar pain 
(44%). Diplopia (38%) and visual loss (30%) are less 
commonly  features of BIH10. To diagnose BIH we 
should have (1) Raised intracranial pressure; (2) 
Normal neurologic examination except  Papilledema 
and an occasionally abducens nerve palsy (3) the 
absence of a space-occupying lesion, or ventricular 
enlargement on computed tomography or magnetic 
resonance imaging; and (4) a normal cerebrospinal 
fluid composition10,11,12.In addition to these 
features CSF manometery is of diagnostic and 
therapeutic importance. CSF  opening pressure greater 
than 250 mm H2O is diagnostic, less than 200 mm 
H2O is normal, and 201 to 249 mm H2O is 
nondiagnostic13.Management  aim is controlling 
symptoms of raised intracranial pressure (ICP) and 
prevention of loss of vision due to Papilledema.Dietary 
modification and weight loss are time part of initial 
managment14,15 , Repeated  lumber puncture are 
sometimes used in patients to control symptom , in 
pregnant women, or in the setting of rapidly declining 
vision to temporarily lower16 and optimize  the CSF 
pressure. Acetazolamide  a carbonic anhydrase 
inhibitor is used  for lowering the intracranial 
hypertension by decreasing CSF production (Doses of 1 
to 2 g ).Surgical treatment is indicated in cases with 
failed medical treatment or rapidly deteriorating vision. 
Generally, the indication for a CSF diversion procedure 
is failed medical treatment or intractable headache17. 
There are many surgical treatment options like 
lumboperitoneal shunt18,19,20 optic nerve sheath 
fenestration21,22, ventriculoperitoneal (VP) 
shunt23,24,25and venous sinus stenting for patients 
of BIH26,27 . Currently Lumboperitoneal shunt is most 
commonly advised to patients of BIH. As vision 
deterioration and headache are the  most common 
presenting and disabling feature of patients with BIH, 
therefore we conducted this study to determine 
outcome of lumboperitoneal shunt in patients with BIH 
in terms of improvement in vision..
Material and methods
We conducted  this Prospective observational  study of 
22 patients operated in neurosurgery unit lady reading 
hospital Peshawar   from Jan 2011 to Jun2014. 
Written consent was obtained from all the patients or 
their relatives All patients of either age and  sex with 
Diagnosed cases of  BIH were included in the study, 
Patients with depressed conscious level, Malignant 
hypertension, Patients with space occupying lesion in 
brain on MRI, Patients unfit for surgery and unwilling for 
surgery were excluded from the study.Pre operative 
funds examination and visual field charting was done in 
all the cases. Pre-operatively CT scan /MRI brain was 
done in all the patients. MR venography was also done 
in all patients.  Cerebrospinal fluid examination was 
performed in all patients. All patients were admitted 
through OPD in ward. Preoperative work up was done in 
all cases. Hematologic tests like FBC,Urea,RBS, and 
Serologic tests like HBS and HCV were done for all 
cases. Lumboperitoneal shunt was done in all cases 
under G.A.
TECHNIQUE OF SURGERY
Position;Lateral decubitus position with both knee 
flexed.
Skin incision: 
1.5 to 2 cm at L3-L4 or L4-L5 level extended down to 
the lumber fascia overlying the spinous processes.  Tilt 
table to 30 degree Reverse Trendelenburg to Increase 
lumbar subarachnoid space. Then Insertion of 
14-gauge Tuohy needle in interspinous space to reach 
into the subarachnoid space, with opening directed 
rostrally. Removal of the trocar with insertion of shunt 
tube ( 8 to 10 cm).stabilization of catheter at back 
wound under lumber fascia with reservoir . 
Abdominal placement: 
Incision is made into anterior abdominal wall, extended 
down and peritoneum is opened. Then subcutaneous 
shunt passer is passed and redirected to back incision. 
shunt catheter stabilized with reservoir at back incision 
is passed through passer, and inserted into peritoneal 
cavity. the wound is then closed.After surgery all 
patients were kept in ward for 4 to 5 days and then 
discharged to home. All patients were followed up till 1 
year, with 2 months interval.Postoperatively clinical 
outcome was measured by History and Fundus 
examination and CT brain. Postoperative follow up was 
clinical with history and Fundoscopy, and radiological 
with CT brain.All data was collected and put in 
Performa. All data was analyzed using SPSS version 
20. Results were expressed in the form of 
tables/graphs/charts.
Results
We studied 22 patients with Diagnosed cases of BIH. 
All patients were female. Age ranged from 18 to 58 
with mean of 38 ± 5 years SD.  In pre operative signs 
and symptoms the commonest was headache which 
was present in all (100%) patients , Visual 
deterioration in 20(90.90%) patient and all (100 %) 
these patients had Papilledema. 6(27.7%) patients 
had vomiting , 6th nerve palsy in  2(9.09%) patients 
(Table no 1) . All patients were investigated to follow 
modified dandy criteria.  CT brain was done in 
10(45.45%) patients. MRI brain with MRV was done in 
all( 100%) patients. CSF manometery showed opening 
pressure from 28cm of H2O to 50 cm of H2O, with 
mean of 39.19. CSF composition was normal in all 
patients. MRI brain showed slit ventricles in 3(13.63%) 
cases. LP shunt was done for all 22(100%) cases. 
Postoperatively clinical outcome was measured by 
History and Fundus examination and CT brain uptill 1 
years by intervals of 2 months follow up. Headache 
improved in 16(72%) patients, Papilledema resolved 
postoperatively in 18(81.81%) cases and same 
number of patients 18(81.81%) showed improvement 
in vision.  4(18%) patients had persistence of 
symptoms postoperatively. Shunt infection was noticed 
in 2(9.09%) cases in first 4 weeks which was 
subsequently managed.  CSF leak was noticed in 
1(4.54%) case for which shunt revision was done 
(Graph no 1).
Table no 1; Pre operative signs and symptoms N=22
 
Graph no 1; Post operative outcome of BIH N=22
Discussion
Benign intracranial hypertension is characterized by 
Raised CSF pressure of unknown Reason. Resistance 
to  CSF outflow  appears to increase, so intracranial 
pressure also increases. Whether the increased 
resisance is due to outflow which is  obstructed at the 
level of the arachnoid granulations or outer lymphatic’s 
flow is unclear ,however BIH can result in blindness if 
inadequately treated but  effective options strategies 
are available 28.The initial criteria suggested by Walter 
Dandy have been modified now called modified dandy 
criteria. Patients who follow these criteria are 
diagnosed as having the BIH. Laboratory evaluation is 
normal but there is raised intracranial pressure29.In 
the review of our 3 years experience with 22 patients 
with IIH who underwent Lumboperitoneal shunts , we 
aimed to determine improvement in visual problems 
after surgery. In our study we had age ranged from 18 
to 58 years with mean of 38.and this correlates with 
Whitely and coworkers who prospectively had  peak 
incidence of disease  in 3rd decade of life30.
The disease is more common in women of child bearing 
age. we had all patients female 22(100%) had BIH in 
three years duration. and explanation is consistent with 
the hormonal theory for pathogenesis of  BIH which 
states that high incidence among obese women  as 
adipocytes covert androstenedione to estrone which 
increases CSF production31. Study conducted by 
Yadav YRetal32 also showed this disease in 90.90% 
patients, which closely correlates to our study. 
Headache and vision deterioration are common 
problems in patients with BIH. We had headache in all 
(100%) patients and vision deterioration in 
20(90.90%) patients. It is comparable with study of 
Corbett and colleagues33, who also had  the same 
incidence (100 % of cases) in their series which 
included 20 patients with BIH.  There are many surgical 
treatment options for BIH management which includes 
Lumboperitoneal shunting, Ventriculoperitoneal 
shunting, and optic nerve sheath decompression. 
Cerebrospinal fluid shunting is the most widely 
performed surgical treatment for BIH and it is useful in 
the treatment of Papilledema, headache, and visual 
loss. We did Lumboperitoneal shunting for all(100%) 
patients. Postoperatively headache and Visual 
symptoms improved in 16(72%), and 18(81.81%) 
consecutively. In another international study by Burgett, 
etal34.described an 82% success rate of postoperative 
headache relief and visual improvement in patients 
with LP shunts. So our results are comparable with their 
results. Purvin VA et al35, had studied 30 patients who 
underwent LP shunting for treatment of BIH. Out of 14 
patients with impaired acuity, 10 eyes (71%) improved 
after shunting, which is less as compared to our 81%. 
on subsequent follow up visits 3(13.63%) patients had 
low pressure headache which was conservatively 
managed.
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